Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes
- PMID: 873095
- DOI: 10.1007/BF01219712
Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes
Abstract
With the artificial pancreas used by the authors, insulin was delivered through a venous infusion and the rate of delivery was adjusted according to data provided by a continuous blood glucose monitor. After different trials we selected control algorithms integrating two parameters: instantaneous blood glucose concentration and increasing or decreasing patterns of blood glucose. A constant basal insulin infusion rate was added and improved the control of glycaemic excursions. Different parameters concerning exogenous insulin homoeostasis were determined. The delay to reach an insulin effect was 18+/-2 min and was shortened by a priming-dose at the beginning of the infusion. The insulin effect remained for 28+/-2 min after the infusion had been stopped, but differences were noted in the morning (21+/-2 min), in the afternoon (32+/-2 min) and during the night (25+/-3 min). Insulin needs were evaluated during meals. Related to the amount of carbohydrates, the doses fell from 0.53 units/hr/g of carbohydrate for breakfast to 0.15 for dinner. From these data, it appears that the efficiency of exogenous insulin exhibits a circadian rhythm.
Similar articles
-
[Clinical and diabetic research of the artificial extracorporeal pancreas].Nouv Presse Med. 1977 May 21;6(21):1837-41. Nouv Presse Med. 1977. PMID: 876830 French.
-
Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics.Diabetes. 1981 Feb;30(2):101-5. doi: 10.2337/diab.30.2.101. Diabetes. 1981. PMID: 7009264 Clinical Trial.
-
Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.Horm Metab Res Suppl. 1979;(8):110-5. Horm Metab Res Suppl. 1979. PMID: 395065 No abstract available.
-
Artificial pancreas: state of the art.Int J Artif Organs. 1988 Jan;11(1):13-26. Int J Artif Organs. 1988. PMID: 3283055 Review. No abstract available.
-
Continuous subcutaneous insulin infusion: a developing tool in diabetes research.Diabetologia. 1980 Jan;18(1):1-4. doi: 10.1007/BF01228294. Diabetologia. 1980. PMID: 6988262 Review. No abstract available.
Cited by
-
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.J Diabetes Sci Technol. 2023 Nov;17(6):1493-1505. doi: 10.1177/19322968231195081. Epub 2023 Sep 25. J Diabetes Sci Technol. 2023. PMID: 37743740 Free PMC article. Review.
-
Automated closed-loop control of diabetes: the artificial pancreas.Bioelectron Med. 2018 Nov 7;4:14. doi: 10.1186/s42234-018-0015-6. eCollection 2018. Bioelectron Med. 2018. PMID: 32232090 Free PMC article. Review.
-
The Discovery of Insulin: An Important Milestone in the History of Medicine.Front Endocrinol (Lausanne). 2018 Oct 23;9:613. doi: 10.3389/fendo.2018.00613. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30405529 Free PMC article. Review.
-
Diabetes Technology: Monitoring, Analytics, and Optimal Control.Cold Spring Harb Perspect Med. 2019 Jun 3;9(6):a034389. doi: 10.1101/cshperspect.a034389. Cold Spring Harb Perspect Med. 2019. PMID: 30126835 Free PMC article. Review.
-
Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes.J Transl Med. 2018 Jun 28;16(1):176. doi: 10.1186/s12967-018-1558-8. J Transl Med. 2018. PMID: 29954380 Free PMC article. Review.